Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Ajax Health
company
About
Ajax Health accelerates medical innovation through capital and capabilities.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $120M
- Industries
- Clinical Trials,Health Care,Medical Device
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
Ajax Health accelerates medical innovation through capital and capabilities.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$215M
Ajax Health has raised a total of
$215M
in funding over 2 rounds. Their latest funding was raised on
Jul 9, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 9, 2018 | Series B | $120M | 1 | — | — | Detail |
| Jan 1, 2017 | Series A | $95M | 1 |
Kohlberg Kravis Roberts
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Ajax Health has made 1 investments. Their most recent investment was on
Apr 27, 2021, when Treeline Biosciences raised $212M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Apr 27, 2021
Treeline Biosciences
|
Series A | $212M | Biotechnology | — |
Investors
Number of Lead Investors
Number of Investors
1
1
Ajax Health is funded by 1 investors.
Kohlberg Kravis Roberts
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Kohlberg Kravis Roberts
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
